14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
Jun 29, 2020 $1.81 $1.87 $1.68 $1.80 460 117
Jun 26, 2020 $1.90 $1.93 $1.78 $1.79 281 760
Jun 25, 2020 $1.81 $1.90 $1.79 $1.90 216 238
Jun 24, 2020 $1.83 $1.86 $1.78 $1.82 188 753
Jun 23, 2020 $1.81 $1.90 $1.81 $1.81 239 513
Jun 22, 2020 $1.80 $1.88 $1.76 $1.81 279 376
Jun 19, 2020 $1.84 $1.95 $1.76 $1.76 204 638
Jun 18, 2020 $1.89 $1.94 $1.83 $1.83 221 438
Jun 17, 2020 $1.90 $1.99 $1.88 $1.88 292 690
Jun 16, 2020 $1.82 $1.92 $1.79 $1.90 307 853
Jun 15, 2020 $1.75 $1.81 $1.65 $1.79 390 673
Jun 12, 2020 $1.82 $1.86 $1.71 $1.75 402 344
Jun 11, 2020 $1.85 $1.91 $1.70 $1.74 631 631
Jun 10, 2020 $1.94 $1.95 $1.88 $1.92 175 432
Jun 09, 2020 $1.93 $1.97 $1.85 $1.91 267 062
Jun 08, 2020 $1.85 $2.00 $1.85 $1.97 326 231
Jun 05, 2020 $2.02 $2.10 $1.86 $1.88 784 712
Jun 04, 2020 $1.98 $2.06 $1.98 $2.01 794 557
Jun 03, 2020 $1.87 $2.15 $1.87 $2.05 1 990 501
Jun 02, 2020 $1.89 $1.98 $1.85 $1.93 829 964
Jun 01, 2020 $1.90 $1.94 $1.83 $1.89 417 013
May 29, 2020 $1.75 $1.94 $1.71 $1.90 1 597 166
May 28, 2020 $1.78 $1.87 $1.71 $1.78 1 770 370
May 27, 2020 $1.80 $1.83 $1.71 $1.78 740 003
May 26, 2020 $1.74 $1.83 $1.69 $1.75 2 813 097
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT